摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(E)-3-(4-(2',2',2'-trifluoroethoxy)styryl)-[ 1,2,4]triazolo[ 3,4-α]phthalazine | 1268243-12-4

中文名称
——
中文别名
——
英文名称
(E)-3-(4-(2',2',2'-trifluoroethoxy)styryl)-[ 1,2,4]triazolo[ 3,4-α]phthalazine
英文别名
3-[(E)-2-[4-(2,2,2-trifluoroethoxy)phenyl]vinyl]-[1,2,4]triazolo[3,4-a]phthalazine;3-[(E)-2-[4-(2,2,2-trifluoroethoxy)phenyl]ethenyl]-[1,2,4]triazolo[3,4-a]phthalazine
(E)-3-(4-(2',2',2'-trifluoroethoxy)styryl)-[ 1,2,4]triazolo[ 3,4-α]phthalazine化学式
CAS
1268243-12-4
化学式
C19H13F3N4O
mdl
——
分子量
370.334
InChiKey
HHYWSNVSJDBENN-JXMROGBWSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.4
  • 重原子数:
    27
  • 可旋转键数:
    4
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.11
  • 拓扑面积:
    52.3
  • 氢给体数:
    0
  • 氢受体数:
    7

反应信息

  • 作为产物:
    参考文献:
    名称:
    Design, Synthesis, and Biological Evaluation of New Cinnamic Derivatives as Antituberculosis Agents
    摘要:
    Tuberculosis, HIV coinfection with TB, emergence of multidrug-resistant TB, and extensively drug-resistant TB are the major causes of death from infectious diseases worldwide. Because no new drug has been introduced in the last several decades, new classes of molecules as anti-TB drugs are urgently needed. Herein, we report the synthesis and structure-activity relationships of a series of thioester, amide, hydrazide, and triazolophthalazine derivatives of 4-alkoxy cinnamic acid. Many compounds exhibited submicromolar minimum inhibitory concentrations against Mycobacterium tuberculosis strain (H(37)Rv). Interestingly, compound 13e, a 4-isopentenyloxycinnamyl triazolophthalazine derivative, was found to be 100-1800 times more active than isoniazid (INH) when tested for its ability to inhibit the growth of INH-resistant M. tuberculosis strains. The results also revealed that 13e does not interfere with mycolic acid biosynthesis, thereby pointing to a different mode of action and representing an attractive lead compound for the development of new anti-TB agents.
    DOI:
    10.1021/jm101510d
点击查看最新优质反应信息

文献信息

  • Design, Synthesis, and Biological Evaluation of New Cinnamic Derivatives as Antituberculosis Agents
    作者:Prithwiraj De、Georges Koumba Yoya、Patricia Constant、Florence Bedos-Belval、Hubert Duran、Nathalie Saffon、Mamadou Daffé、Michel Baltas
    DOI:10.1021/jm101510d
    日期:2011.3.10
    Tuberculosis, HIV coinfection with TB, emergence of multidrug-resistant TB, and extensively drug-resistant TB are the major causes of death from infectious diseases worldwide. Because no new drug has been introduced in the last several decades, new classes of molecules as anti-TB drugs are urgently needed. Herein, we report the synthesis and structure-activity relationships of a series of thioester, amide, hydrazide, and triazolophthalazine derivatives of 4-alkoxy cinnamic acid. Many compounds exhibited submicromolar minimum inhibitory concentrations against Mycobacterium tuberculosis strain (H(37)Rv). Interestingly, compound 13e, a 4-isopentenyloxycinnamyl triazolophthalazine derivative, was found to be 100-1800 times more active than isoniazid (INH) when tested for its ability to inhibit the growth of INH-resistant M. tuberculosis strains. The results also revealed that 13e does not interfere with mycolic acid biosynthesis, thereby pointing to a different mode of action and representing an attractive lead compound for the development of new anti-TB agents.
查看更多